JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khalifa, M.
Right arrow Articles by Turgeon, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khalifa, M.
Right arrow Articles by Turgeon, J.

Vol. 288, Issue 2, 858-865, February 1999

Block of Potassium Currents in Guinea Pig Ventricular Myocytes and Lengthening of Cardiac Repolarization in Man by the Histamine H1 Receptor Antagonist Diphenhydramine1

Majed Khalifa, Benoit Drolet, Pascal Daleau, Christophe Lefez, Marcel Gilbert, Sylvain Plante, Gilles E. O'Hara, Onil Gleeton, Bettina A. Hamelin and Jacques Turgeon

Quebec Heart Institute, Laval Hospital, Faculty of Pharmacy, Laval University (M.K., B.D., B.A.H., J.T.), and Faculty of Medicine, Laval University (P.D., M.G., J.T.), Sainte-Foy, PQ, Canada

Treatment with second generation histamine H1 receptor antagonists has been associated with lengthening of the Q-T interval and proarrhythmia. Similarly, lengthening of the Q-T interval has been reported in patients after overdosing with diphenhydramine (DPH), a first generation agent. Therefore, our study was designed 1) to assess effects of DPH on cardiac repolarization and 2) to characterize effects of the drug on major voltage-dependent cardiac K+ currents. First, we noticed that oral administration of DPH at usual dosages to healthy volunteers or to patients (prior to angioplasty) was associated with prolongation of the Q-Tc interval. Although this effect was modest in most individuals, Q-Tc was increased more than 20 ms in 7 of 20 patients. Second, we noticed that exposure of isolated guinea pig hearts to DPH 10-5 M caused a lengthening of monophasic action potential duration. This effect was potentiated by the combined perfusion of other K+ channel blockers such as indapamide. Finally, experiments performed with the patch-clamp technique demonstrated unequivocal block of the rapid component of the delayed rectifier (IKr) by DPH; however, IC50 determined for block of IKr (3 · 10-5 M) is ~40-fold greater than plasma concentrations of the drug measured at usual dosages (7 · 10-7 M). Consequently, in agreement with the long-term clinical use of the drug, prolongation of cardiac repolarization should be minimal in most patients at usual dosages but may be observed with overdosing. Nevertheless, caution remains since excessive lengthening of cardiac repolarization may occur after administration of DPH with other drugs due to 1) concomitant block of other ionic currents or 2) pharmacokinetic interactions leading to toxic concentrations of DPH.


0022-3565/99/2882-0858$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Toxicol SciHome page
A. K. Peters, M. Steemans, E. Hansen, N. Mesens, G. R. Verheyen, and P. Vanparys
Evaluation of the Embryotoxic Potency of Compounds in a Newly Revised High Throughput Embryonic Stem Cell Test
Toxicol. Sci., October 1, 2008; 105(2): 342 - 350.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. D. Guth
Preclinical Cardiovascular Risk Assessment in Modern Drug Development
Toxicol. Sci., May 1, 2007; 97(1): 4 - 20.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Sharma, P. Pibarot, S. Pilote, J. G. Dumesnil, M. Arsenault, P. M. Belanger, B. Meibohm, and B. A. Hamelin
Modulation of Metoprolol Pharmacokinetics and Hemodynamics by Diphenhydramine Coadministration during Exercise Testing in Healthy Premenopausal Women
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1172 - 1181.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. L. Hamlin, A. Kijtawornrat, B. W. Keene, and D. M. Hamlin
QT and RR Intervals in Conscious and Anesthetized Guinea Pigs with Highly Varying RR Intervals and Given QTc-Lengthening Test Articles
Toxicol. Sci., December 1, 2003; 76(2): 437 - 442.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. R. Gralinski
The Dog's Role in the Preclinical Assessment of QT Interval Prolongation
Toxicol Pathol, January 1, 2003; 31(1_suppl): 11 - 16.
[Abstract] [PDF]


Home page
CirculationHome page
B. Drolet, G. Rousseau, P. Daleau, R. Cardinal, and J. Turgeon
Domperidone Should Not Be Considered a No-Risk Alternative to Cisapride in the Treatment of Gastrointestinal Motility Disorders
Circulation, October 17, 2000; 102(16): 1883 - 1885.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. Drolet, A. Emond, B. Pharm, V. Fortin, P. Daleau, G. Rousseau, R. Cardinal, and J. Turgeon
Vitamin K Modulates Cardiac Action Potential by Blocking Sodium and Potassium Ion Channels
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 267 - 273.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.